Beginning July 1, 2026, Medicare beneficiaries may qualify for the new Medicare GLP-1 Bridge Program, which provides access to certain GLP-1 weight loss medications for a reduced monthly cost. Eligibility is based on your BMI, medical history, and enrollment in a Medicare Part D prescription drug plan. Body mass index (BMI) must be ≥35 prior to starting GLP-1 therapy to qualify. Medicare patients with significant other medical problems may also qualify.
Table of Contents
What Is the Medicare GLP-1 Bridge Program?
For years, Medicare generally excluded medications prescribed solely for weight loss. As obesity rates increased and research demonstrated the health benefits of GLP-1 medications, pressure grew to improve access for Medicare beneficiaries.
Beginning July 1, 2026, Medicare is launching the Medicare GLP-1 Bridge Program, a temporary demonstration program designed to expand access to obesity treatment medications for qualifying beneficiaries.
The program is currently scheduled to run through December 31, 2027.
For many patients, this may represent the first opportunity to obtain GLP-1 treatment through a Medicare-supported pathway.
Which Medications Are Included?
Current medications included in the Bridge Program may include:
- Wegovy
- Oral Wegovy
- Zepbound
- Foundayo
Medication availability and coverage rules may change as CMS updates the program.
Who Qualifies for the Medicare GLP-1 Bridge Program?
To qualify, patients must:
- Eligible for Medicare. Typically this is for patients over 65 years old
- Be enrolled in a Medicare Part D prescription drug plan
- Meet BMI and medical qualification requirements
Unlike previous Medicare coverage pathways, qualification is largely based on BMI and associated medical conditions.
Body Mass Index (BMI) 35 or Higher
Patients with a body mass index (BMI) of 35 or greater may qualify based on obesity alone when participating in ongoing lifestyle modification efforts.
This category is expected to include many patients with severe obesity who previously had limited access to GLP-1 treatment through Medicare.
Example
A patient with:
- BMI of 38
- No diabetes
- No cardiovascular disease
May still qualify under this category.
Calculate Your Body Mass Index (BMI)
Calculate Your BMI
Medicare GLP-1 Bridge Program:
- BMI 35+ may qualify
- BMI 30+ with heart failure, uncontrolled hypertension, or chronic kidney disease
- BMI 27+ with pre-diabetes, prior heart attack, stroke, or symptomatic peripheral artery disease
BMI 30 or Higher
Patients with a BMI of 30 or greater may qualify if they also have one of the following conditions:
- Heart failure
- Uncontrolled hypertension
- Chronic kidney disease
Example
A patient with:
- BMI of 31
- Chronic kidney disease
May qualify even if they do not have diabetes or previous cardiovascular events.
BMI 27 or Higher
Patients with a BMI of 27 or greater may qualify if they have:
- Pre-diabetes
- Previous heart attack
- Previous stroke
- Symptomatic peripheral artery disease
This category allows patients with lower BMI levels but significant cardiovascular risk factors to access treatment.
Example
A patient with:
- BMI of 28
- Prediabetes
May qualify for the program.
Why This Matters
Obesity is now recognized as a chronic medical condition that contributes to:
- Heart disease
- Stroke
- Diabetes
- Sleep apnea
- Joint pain
- Reduced quality of life
GLP-1 medications have demonstrated significant benefits beyond weight loss, including improvements in metabolic health and cardiovascular outcomes.
The Medicare GLP-1 Bridge Program represents one of the largest expansions of obesity treatment access for seniors to date.
How Flow Wellness Can Help
Flow Wellness does not bill Medicare directly for weight loss treatment.
However, our providers can help determine whether you may qualify for the Medicare GLP-1 Bridge Program by reviewing:
- Current BMI
- Weight history
- Medical conditions
- Previous GLP-1 treatment
- Metabolic health goals
If you are interested in exploring your options, learn more about our GLP-1 medical weight loss program or contact Flow Wellness to schedule a consultation.
Key Takeaways
- The Medicare GLP-1 Bridge Program launches July 1, 2026.
- Patients must be enrolled in Medicare Part D.
- BMI 35+ may qualify without additional medical conditions.
- BMI 30+ may qualify with heart failure, uncontrolled hypertension, or chronic kidney disease.
- BMI 27+ may qualify with prediabetes, previous heart attack, stroke, or peripheral artery disease.
- Flow Wellness can help review eligibility and discuss treatment options.
Updated: May 2026
Medically reviewed by Dr. Kevin Jones, MD
Board Certified Obesity Medicine
Flow Wellness
Frequently Asked Questions
What is the Medicare GLP-1 Bridge Program?
A temporary Medicare demonstration program beginning July 1, 2026 that expands access to certain GLP-1 weight loss medications for qualifying beneficiaries.
Does Medicare cover Wegovy in 2026?
Some Medicare beneficiaries may qualify for Wegovy through the Medicare GLP-1 Bridge Program if they meet BMI and medical criteria.
Does Medicare cover Zepbound?
Eligible beneficiaries may qualify for Zepbound through the Bridge Program if they meet program requirements.
What BMI qualifies for Medicare GLP-1 coverage?
Patients may qualify at:
- BMI 35 or higher
- BMI 30 or higher with qualifying medical conditions
- BMI 27 or higher with certain cardiovascular risk factors
Can I qualify if I have prediabetes?
Yes. Patients with a BMI of 27 or greater and prediabetes may qualify.
What if I already lost weight on Wegovy or Zepbound?
Medicare has not yet clarified how patients whose BMI has fallen below qualification thresholds due to successful treatment will be evaluated.
Does Flow Wellness accept Medicare?
Flow Wellness does not bill Medicare directly for weight loss treatment. However, our providers can help review your eligibility and discuss available treatment options.
Related GLP-1 Resources
GLP-1 Weight Loss & Microdosing
Personalized GLP-1 Programs For Lasting Results GLP 1 Weight Loss & Microdosing Clinics In Bend & Seattle and serving CA, OR, and WA via telehealth
How Much Does GLP-1 Pill Cost?
If you’ve been hearing about the new GLP-1 pill options, one of the most common questions is simple: how much does a GLP-1 pill cost
Understanding Body Mass Index (BMI): A Guide to Its Role in Medical Weight Loss
Body Mass Index (BMI) is a numerical value that has become a universal metric in assessing the overall body fat and health status of an
